Western General Hospital
Edinburgh, Midlothian, EH4 2XU, United Kingdom
Location contact
Helen Jones, MBChB
SUB_INVESTIGATOR
Kieran P Nunn, MBBS, BSc (hons), FRCA, FFICM
CONTACT
Zoeb Jiwaji, MBBCh, PhD, MA
CONTACT
NCT Number: NCT07470216
Many older people can experience confusion, memory problems, or a decline in their thinking after major surgery. These problems are sometimes called 'postoperative neurocognitive disorders' or PND and can affect recovery and a person's ability to live independently.
The investigators want to find out the best way to study these problems in older patients undergoing surgery. This is a 'feasibility study', which means we are testing the research methods. The investigators want to see if it is possible to ask participants to do memory tests and give blood samples before and after their operation. The investigators are hoping to include around 40 patients over 2 years in this study.
The investigators will compare performance in memory (cognitive assessment) findings before and after surgery and link this to data taken from the anaesthetic, including the types of drugs used, duration, brain features from processed electroencephalogram monitoring and standard recommended monitoring. In addition the investigators will link this to blood sample markers of brain health and function (biomarkers).
The results of this study will help the investigators plan a much larger study in the future, with the ultimate goal of making surgery safer for the brain.
Trial opening soon.
Get Notified70 year and older
All sexes
Observational
Edinburgh, Midlothian, EH4 2XU, United Kingdom
Helen Jones, MBChB
SUB_INVESTIGATOR
Kieran P Nunn, MBBS, BSc (hons), FRCA, FFICM
CONTACT
Zoeb Jiwaji, MBBCh, PhD, MA
CONTACT
SUMMARY
Older patients can experience significant difficulties with memory and thinking (known as cognitive problems) after major surgery. The specific reasons in this vulnerable group are not yet clearly understood.
CAPSULAR is a single-centre feasibility research project at the Western General Hospital, Edinburgh, that aims to find the best way to conduct detailed research into this problem.
Objectives:
Main Aim:
Secondary Aims:
We plan to recruit 40 patients aged ≥ 70 who are scheduled for colorectal or urological surgery lasting over one hour. Participants will be those already attending the POPS (Perioperative Medicine for Older People undergoing Surgery) clinic.
The study will measure success based on the percentage of eligible patients who agree to take part, complete the one-week cognitive screening, and provide all the necessary blood and data samples.
This research will provide the crucial initial evidence needed to plan future definitive trials exploring whether altering anaesthetic or surgical care can safely reduce brain problems for older and frailer patients.
2 INTRODUCTION
2.1 BACKGROUND
Postoperative neurocognitive disorders (PND) represent a spectrum of cognitive impairments that can arise after surgery, ranging from acute, reversible, postoperative delirium to more persistent, and sometimes subtle, cognitive decline. These disorders are particularly common in older adults, with reported incidence rates for postoperative delirium as high as 40% following major elective surgery. The consequences are significant, including prolonged hospital stays, increased patient morbidity and mortality, and a greater likelihood of long-term cognitive impairment, which can profoundly reduce a patient's quality of life and independence. Additionally, there may be further impact economically and upon the formal and informal care sectors for example new dependence on aids.
The investigators' previous work with the Perioperative Care for Older People Undergoing Surgery (POPS) Clinic at the Western General Hospital, Edinburgh, identified that 21% of patients scheduled for major surgery had previously unrecognised pre-operative cognitive impairment. This cohort subsequently experienced a high incidence of PND, particularly delirium, affecting 40% of those who underwent emergency surgery and 5% of those undergoing elective surgery. This highlights a vulnerable patient population in whom the risks of postoperative cognitive decline are substantial.
The pathophysiology of PND is thought to be multifactorial, involving interplay between patient-specific risk factors (e.g., advanced age, frailty, pre-existing cognitive deficits) and procedural factors, such as surgical stress, systemic inflammation, and anaesthetic technique. Previous research has often included younger and less frail individuals, leaving a critical knowledge gap concerning those elderly and frailer patients who are possibly most at risk.
Given the increasing trend towards older patients undergoing major surgery, there is therefore, an urgent need for research focused specifically on elderly and frail patients to identify reliable risk factors. This includes physiological and molecular biomarkers predictive of PND. This knowledge will enable us to better identify at-risk patients to inform consent, guide preventative resources, and stratify participants for future trials of therapeutic interventions.
2.2 RATIONALE FOR STUDY
One near-universal criticism of the existing literature in this area has been that study cohorts have not been of a sufficiently advanced age. The investigators' research location hospital and clinic stream enables them to set recruitment at 70 years of age or over, as one in five, over-75 year olds, are predicted to undergo surgery from 2030.
While the pilot data established a high incidence of PND in a high-risk cohort, the investigators now need to investigate and categorise the nature of PND with greater accuracy and determine if it is feasible to robustly investigate the impact of perioperative factors on cognitive outcomes.
This project aims to address this evidence gap. The investigators will conduct a prospective feasibility study to establish the practicalities of performing detailed, domain-specific cognitive testing in a high-risk, frail, older patient population at baseline (preoperatively) and postoperatively. This will allow them to accurately quantify the incidence of new or worsening cognitive impairment following major surgery. Furthermore, the investigators will assess the feasibility of systematically collecting detailed data on anaesthetic technique, including intra-operative processed EEG metrics, and obtaining serial blood samples for biomarker analysis. Finally the investigators will assess proxy- patient impact and economic markers such as predicted vs. actual length of stay, change to living arrangements and provision of new aids.
The investigators hypothesize that it is feasible to recruit this cohort and perform these detailed assessments. This work is critical as it will provide the foundational data necessary to design a larger, adequately powered trial to determine whether specific anaesthetic practices, such as pEEG-guided anaesthesia to minimise burst suppression, can mitigate the risk of long-lasting postoperative cognitive decline in vulnerable patients. It will inform the design of research aimed at generating data to help identify at-risk patients, possibly identify modifiable factors and quantify the incidence which would help improve the accuracy of pre-surgery counselling.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CO-ENROLMENT
Preoperative and Postoperative MoCA
Biomarkers assessed will be a panel linked to brain injury, inflammation, and cognitive impairment in non-ICU populations.
Time frame: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The overall aim is to test the feasibility of this research being conducted on a larger scale. The primary outcome assesses the proportion of eligible patients who consent and then undergo pre- and post-operative cognitive testing.
Time frame: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then provide pre-, immediately-post-operative and pre-discharge biomarker blood samples (additional tubes/samples from routine blood-lets).
Time frame: The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then have a complete intraoperative data-set collected.
Time frame: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
Analysis of the performance in the Montreal Cognitive Assessment (MoCA) tool allows us to both analyse incidence, but also features of, any identified cognitive changes across the timespan of the patients preparation and undertaking of surgery.
Time frame: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
New support for independent living or new dependence will be recorded at the point the patient leaves the study in order to better understand this and plan for the economic impact analysis in a future study.
Contact information is provided by the study sponsor or research team.
Kieran P Nunn, MB BS, BSc(h), FRCA, FFICM
CONTACT
Zoeb Jiwaji, MBBCh, PhD, MRCP, FRCA, FFICM
CONTACT
University of Edinburgh
Other
Acronym: CAPSULAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06182995
Brain Diseases, Central Nervous System Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT05637801
Alzheimer Disease, Alzheimer Disease 1
Gilbert, Arizona, United States
View Trial DetailsNCT04033510
Arrhythmias, Cardiac, Atrial Fibrillation
Colorado Springs, Colorado, United States
View Trial DetailsNCT05754021
Alzheimer Disease, Alzheimer Disease, Early Onset
Houston, Texas, United States
View Trial Details